Anticardiolipin antibodies in acute rheumatic fever and chronic rheumatic heart disease: Is there a significant association?
Articles > Article · 1996
Authors: N NARIN, Necil KÜTÜKÇÜLER, F NARIN, Gökhan KESER, E DOGANAVSARGIL
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, Journal Indexed in SCI Expanded, International, 1996, vol 14, pp 567-569
Summary
Objective. The incidence and significance of IgG and IgM anticardiolipin in antibodies (aCLa) in patients with acute rheumatic fever (ARF), chronic rheumatic heart disease (CRHD) and streptococcal pharyngitis have been investigated in order to determine whether these antibodies play an important role in the pathogenesis and if they are markers that can be used to confirm disease activity.